Abstract: γδ Tcells are a subpopulation of lymphocytes expressing heterodimeric T-cell receptors composed of γ and δ chains. They are morphologically and functionally heterogeneous, innate yet also adaptive in behavior, and exhibit diverse activities spanning immunosurveillance, immunomodulation, and direct cytotoxicity. The specific responses of γδ Tcells to allografts are yet to be fully elucidated with evidence of both detrimental and tolerogenic roles in different settings. Here we present an overview of γδ T-cell literature, consider ways in which their functional heterogeneity contributes to the outcomes after transplantation, and reflect on methods to harness their beneficial properties. (Transplantation 2018;102: 1983 g d T cells are a highly conserved lymphocyte subpopulation characterized by both innate and adaptive properties. They are physiologically heterogeneous with functions that include immune surveillance for epithelial dysregulation, antigen recognition with characteristic expansion kinetics, and diverse cytokine and chemokine production.
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(Transplantation 2018; 102: 1983-1993) g d T cells are a highly conserved lymphocyte subpopulation characterized by both innate and adaptive properties. They are physiologically heterogeneous with functions that include immune surveillance for epithelial dysregulation, antigen recognition with characteristic expansion kinetics, and diverse cytokine and chemokine production. 1 γδ T cells underpin the initiation and propagation of the immune response through antigen presentation, interactions with dendritic cells, and priming of αβ T cells. γδ T cells also have a role in the modulation of immune responses through suppressing lymphocyte proliferation, promoting peripheral differentiation of B lymphocytes, and controlling circulating levels of immunoglobulin. [2] [3] [4] A major limitation to transplantation is the requirement for immunosuppression to control the immune responses that culminate in allograft rejection. 5 γδ T cells are well positioned to contribute to the allograft rejection response particularly as a bridge between innate and adaptive immunity. Here we present current perspectives on γδ T cell development, classification, and physiology and systematically review current literature regarding their function in transplantation.
gd T CELL DEVELOPMENT
In contrast to the ubiquitous αβ T cells, γδ T cells are typified by a heterodimeric T-cell receptor (TCR) consisting of transmembrane γ and δ chains. γδ T cells comprise between 0.5% and 6% of total circulating lymphocytes, 4-10% of circulating cluster of differentiation (CD)3 + cells, and approximately 10-50% of tissue-resident T cell populations. [6] [7] [8] Typically, γδ T cells are double negative (CD3 + CD4 − CD8 − ), although CD4 + , CD8αα + , CD8β + , and CD4 + CD8 + populations have been described. [9] [10] [11] The 150 kb T-cell receptor γ (TRG) locus encoding γ variable-joining-constant regions is found on chromosome 7p15, whereas the δ-encoding T-cell receptor (TRD) locus is found on chromosome 14q11.2 between the V and J segments of the αTCR locus. [12] [13] [14] [15] TRG sequences are broadly common between individuals, whereas TRD are unique to each person. 7 T-cell receptor formation is contingent upon V(D)J rearrangement. Despite restricted V segments within TRD and TRG loci, γδ TCRs have significant theoretical junctional diversity with a potential 10 18 junctional recombinations compared with 10 15 for αβ TCR and 10 11 for immunoglobulins. 12, 16 However, this theoretical diversity is not realized: γδ T-cell ontogeny results in distinct subpopulations that arise from the thymus during discrete developmental windows. 17, 18 Both αβ and γδ T cells share a common progenitor-the double negative (DN) thymocyte (CD4
19,20 αβ lymphocyte precursors transition from DN to double positive (DP) thymocytes (CD4 + CD8 + ) before ultimately expressing either CD4 or CD8 as single positive thymocytes. At the DN stage, thymocytes display either a pre-TCR or γδ TCR complex. Historically this was thought to signify lineage commitment. However, thymocytes expressing the γδ TCR complex were subsequently manipulated to differentiate into αβ as well as γδ T cells. 21 Recently, γδ TCR stimulation strength within the thymic microenvironment has been proposed as a model able to account for this observation. 22 Strong γδ TCR stimulation of immature DN thymocytes favors γδ T-cell lineage commitment through the ERK/EGR signaling pathway, whereas weak stimulation favors αβ TCR development. 6, 23 γδ T cells have been suggested to play a key role in neonatal immunity during maturation of the αβ compartment. 24 γδ T cells emerge from the foetal thymus in distinct waves. In mice, an initial wave of Vγ5Jγ1Cγ1 γδ T cells migrates to the epidermis between day 14 and 18. 6 These dendritic epidermal T cells (DETCs) express a Vδ1Vγ5 TCR and are sonamed due to their characteristic morphology, with apically anchored dendrites at squamous keratinocyte junctions and highly mobile basal dendrites. 25 DETCs are the major population of epidermal T lymphocytes in mice and rats, whereas smaller populations of γδ TCR + epidermal lymphocytes have been described in humans. 26, 27 Tissue-resident γδ T cells survey their environment for molecular stress signatures, with key roles demonstrated in negative regulation of cutaneous malignancy and wound healing. [28] [29] [30] [31] A second wave of γδ T cells migrate to mucosal sites including the reproductive tract, tongue, peritoneal cavity, lung, liver, dermis, and secondary lymphoid organs and are preprogrammed to produce interleukin-17 (IL-17). 16, 32 Subsequent waves establish IL-4 and IFN-γ producing γδ T cell populations in secondary lymphoid tissue, lung, liver and intestinal epithelium. 32 In contrast to these oligoclonal populations, however, studies of human cord blood (CB) have revealed a distinct polyclonal γδ T cell population with highly diverse pairings of δ and γ gene segments not seen in adults. These CB γδ T cells exhibit weak cytotoxic potential and an altered cytokine profile. 33, 34 gd T CELL CLASSIFICATION In humans, γδ T cells can be broadly classified by the TCR δ chain into Vδ2 positive and Vδ2 negative. Their structural and functional heterogeneity means that γδ T cells cannot be regarded as a homogeneous population of cells with a single physiological role.
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Vd2 Positive gd T Cells Vδ2 γδ T cells account for >70% of circulating peripheral γδ T cells, and the δ2 chain is almost always paired with γ9. Vδ2Vγ9 γδ T cells are exclusively found in humans and higher primates. 36 There are 4 functional phenotypes-naïve, central memory (CM), effector memory (EM), and terminally differentiated effector memory (T EMRA )-which have individual surfacemarker phenotypes, distributions and functions (Table 1 ).
36
Vδ2Vγ9 γδ T cells recognize and proliferate after exposure to pyrophosphate-containing phosphoantigens. 37 Intracellular accumulation of such antigens occurs in dysregulated metabolism of tumor cells, as well as after treatment with aminobisphosphonates, such as zoledronic acid. Vδ2Vγ9 γδ T cells lyse pediatric hepatocellular carcinoma cell lines in vitro as well as malignant melanoma in vivo. [38] [39] [40] Aminobisphosphonates have also been successfully used to expand peripheral circulating γδ T cells in vivo within human cancer immunotherapy trials. 41 Recognition of phosphoantigen also underpins the antimicrobial property of γδ T cells. (E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate is a potent Vδ2Vγ9 activator produced by Mycobacterium tuberculosis, Mycobacterium leprae, Plasmodium falciparum, and Listeria monocytogenes.
1,42-47
Vd2 Negative gd T Cells
Vδ2
neg γδ T cells are a heterogeneous group with TCRs comprised of Vδ1, δ3, or δ5 and Vγ2, γ3, γ4, γ5, or γ8. Vδ1 γδ T cells predominate in mucosa and at epithelial surfaces where they comprise 10-50% of tissue-resident T cells. 48, 49 They function as constant immune surveyors for tissue dysregulation, and after pathogen exposure promote a potent inflammatory response through production of IL-17 in a TLR4 signaling-dependent manner. 50 A comprehensive characterization of their ligands remains elusive, but is known to include MHC class I related chain A (via NKG2D), endothelial protein C receptor, HLA-E (via CD93/NKG2A/C receptor), and other HLA Ib proteins such as heat shock proteins. 51, 52 Vδ2 neg γδ T cells proliferate substantially in response to numerous viruses including cytomegalovirus (CMV), EpsteinBarr virus (EBV), and human immunodeficiency virus. [53] [54] [55] This was first demonstrated in renal allograft recipients, with subsequent work ascertaining the generality of this expansion. Exposure to CMV in utero produces a Vδ2 neg expansion akin to that seen in adults, as does CMV reactivation after allogeneic hematopoietic stem cell transplantation (alloHSCT). 56, 57 Expanded Vδ2 neg γδ T cells are skewed toward a terminally differentiated effector memory phenotype ( Table 2) .
58-60 They highly express perforin, granzyme B, and CD158 b/j with lower expression of CD94/NKG2A. 58 Vδ2 neg γδ T cells have a demonstrable role in the control of CMV disease and limitation of CMV-mediated damage, particularly in susceptible populations such as transplant recipients.
Vδ2 neg γδ T cells infiltrate various solid tumors and demonstrate antitumor, protumor, and immunosuppressive functions. 35 Vδ1 + γδ T cells lyse malignant melanoma cells and are associated with early tumor stage and the absence of metastatic disease. 39 However, their effects in colon cancer are the opposite, where they are major producers of IL-17 and are associated with disease progression. 61 In the context of breast cancer, infiltrating Vδ1 + γδ T cells have been observed to suppress naïve and effector T cells. 62 
ALLOGRAFT RESPONSES
Although the function of γδ T cells is, to a certain extent, ontogenetically determined, they nevertheless retain a degree of functional plasticity dependent upon the activating microenvironment and cytokine milieu. The summary presented below offers a systematic overview by transplanted organ type, highlighting the distinct roles of γδ T cells in each tissue.
Kidney

Ischemia Reperfusion Injury
Ischemia reperfusion injury is an inevitable result of nephrectomy with microvascular dysfunction, hypoxia, and parenchymal damage triggering a vigorous, classically innate, immune response. 63 The duration of warm ischemia correlates with long-term graft failure and mortality. 64 Similarly, prolonged cold ischemia time also increases the risk of graft loss. 65 γδ T cells are implicated in the evolution of the initial ischemic insult through recruitment of classical adaptive immune cells, illustrating their transitional immune functions. Early infiltration of γδ T cells after ischemic insult results in αβ T cell infiltration and subsequent renal tubule damage (Figure 1) . 66, 67 γδ T cell knockout mice display reduced ischemia reperfusion injury. 68 
CMV Infection
In transplantation, CMV infection is associated with increased acute rejection rates, graft damage and loss, opportunistic infections, cardiovascular risk, graft artery stenosis, and posttransplantation diabetes. 69 Posttransplantation, expanded CMV-specific Vδ2 neg cells comprise Vδ1 + , Vδ3 + , and Vδ5 + populations that account for the significantly increased numbers of γδ T cells. 60 The clinical implications of γδ T cell functionality are significant: late expansion of Vδ2 neg γδ T cells is associated with more symptomatic CMV disease, including pyrexia, hepatitis, and leukopenia; higher CMV antigenemias; and the emergence of mutant CMV strains. 49, 70 Patients with primary CMV infection have later Vδ2 neg γδ T cell expansion as do those with early-onset CMV disease post transplantation. In contrast, patients with late-onset CMV disease have an earlier Vδ2 neg γδ T cell expansion which is associated with a reduced risk of recurrent CMV disease. 71 Despite this, clinical outcomes do not appear to differ between early-onset and late-onset disease, with expanded Vδ2 neg γδ T cells also able to ameliorate CMV infection independently of expansion kinetics. 70 CMV-expanded Vδ2 neg populations have also been observed in heart and lung transplant recipients. 72 Problematically, the anti-CMV cytotoxic functionality of γδ T cells may ultimately result in renal allograft damage through donor-specific antibody (DSA)-mediated antibodydependent cellular (ADCC) toxicity. 73 DSAs opsonize stromal cells in vitro resulting in γδ T cell-mediated ADCC, and in vivo γδ T cells localize to endothelial cells during episodes of acute antibody-mediated rejection. CD16, a low-affinity IgG Fc receptor, is highly expressed by activated γδ T cells and is able to promote ADCC in a TCR-independent manner, resulting in degranulation of cytolytic enzymes, high expression of granzyme B and perforin, and IFN-γ production. 73, 74 The response is potentiated by IL-12 and IFN-α, both of which are produced by monocytes and dendritic cells during CMV infection. 69 For patients with DSA, ADCC mediated by 
CMV-expanded Vδ2
neg γδ T cells may be clinically significant, with estimated glomerular filtration rate inversely correlating to the percentage of CMV-induced γδ T cells at 1 year. 73 
Malignancy
A role for γδ T cells in posttransplantation malignancy has also been described. In a longitudinal case-control study of 18 renal transplant recipients, those who subsequently developed malignancies were CMV negative and had significantly lower Vδ2 neg γδ T cells as a proportion of total lymphocytes. By contrast, a CMV-induced Vδ2 neg γδ T-cell expansion was associated with a decreased risk of malignancy, suggesting a role for γδ T cells in immunosurveillance. 75 Furthermore, the action of CMV-expanded γδ T cells in response to epidermoid carcinoma or Burkitt lymphoma cell lines appears potentiated, with significantly increased IFN-γ production compared with CMV-naïve renal allograft recipients who had subsequently developed cancer. 75, 76 Further evidence supporting the protective role of γδ T cells is provided by a retrospective cohort study of 13 patients with stage 3 renal cell carcinoma, where there was a positive correlation between peripheral blood numbers of γδ T cells and survival. 77 However, others have not found statistically significant increases in the odds of cancer development after renal transplantation in relation to γδ T-cell immune phenotype. 78 
Allograft protection
The precise role γδ T cells play in renal allograft survival is unclear. For example, there is evidence that γδ T cells may be protective. Rats fed oral alloantigen of donor splenocytes have significantly prolonged renal allograft survival associated with increased levels of graft-infiltrating CD8
+ γδ regulatory T (Treg) cells producing IL-10. 79 This protective effect can be transferred between rats via adoptive cell transfer. However, no increased graft survival occurs if the cell transfer is TCR γδ depleted. 79 Evidence regarding the activation and recruitment of γδ T cells during rejection episodes is also mixed. Lower frequencies of CD8 + γδ T cells have been observed in patients experiencing acute or chronic rejection compared to healthy controls. 80 In contrast, a significantly increased presence of monocytes, macrophages, and TCR αβ + or TCR γδ + lymphocytes has been detected within allografts of patients experiencing acute rejection. 81 Similarly, γδ T cells have been found in terminally rejected transplant nephrectomies although their presence in episodes of acute cellular rejection does not significantly alter long-term graft function. 76 Hence, although γδ T cells may result in allograft damage through promulgating ischemia reperfusion injury, their role as direct effector cells is not definitive. It is also important to balance these effects in light of their activity in posttransplantation infection and tumor immunosurveillance. No single role can be seen as dominant. 82, 83, 87 Similarly to lung transplantation, IL-17 production by γδ T cells after cardiac transplantation profoundly alters graft outcomes despite initial early evidence suggesting no role for γδ T cells in cardiac allograft rejection. [88] [89] [90] [91] γδ T cells are the major producer of intracardiac allograft IL-17 and are implicated in both acute and chronic allograft dysfunction. 92, 93 Depletion of γδ T cells prolongs graft survival, reduces serum IL-17, reduces inflammatory cell infiltrates, and increases graft infiltration by CD4
Lung and Heart
IL-17 is critical in the pathogenesis
+ Treg cells. [93] [94] [95] [96] In acute allograft rejection, γδ T cells expand after exposure to long pentraxin 3, an acute phase protein, with IL-17 production stimulated by IL-23 and IL-1β production from dendritic cells, themselves potentiated by high mobility group box 1 (HMGB1). 97 This HMGB1-TLR4-IL-23-IL-17A axis is also crucial for the pathogenesis of ischemia reperfusion injury. 98 The peripheral blood composition of γδ T cells after cardiac allograft transplantation is also altered, with an increased proportion of CD25 − , HLA-DR − Vδ1 + γδ T cells that proliferate in response to IL-2. 99 In mice, knockout of γδ T cells abrogates cardiomyocyte apoptosis after transplantation. 100 γδ T cells accumulate in the endocardium and myocardium of patients over time, and clonal expansion of Vγ3Jγ2.1Cγ2 transcripts has been found in the coronary arteries of patients who experience chronic rejection. [101] [102] [103] γδ T cells also have a role in the pathogenesis of cardiac allograft vasculopathy. Regulated on activation, normal T cell expressed and secreted, also known as CCL5, is a chemokine that recruits mononuclear cells to the vascular endothelium and precedes intimal thickening. 104 Regulated on activation, normal T cell expressed and secreted is produced by γδ T cells which triple in number over the development of mouse allograft vasculopathy, and colocalizes with infiltrating mononuclear cells at sites of intimal thickening in the coronary arteries of human explanted hearts. 105 γδ T cells can also mediate allograft dysfunction via IL-12 and NKG2D pathways: blockade of either pathway results in reduced numbers of IL-17/IFNγ-producing γδ T cells and ameliorates postischemic cardiomyocyte function. 106, 107 Data from both cardiac and pulmonary transplantation highlight how the previously well-described ability for γδ T cells to produce IL-17 ultimately expediates graft rejection via numerous pathways including acute CD4 + and CD8 + lymphocyte recruitment and chemokine production orchestrating a chronic inflammatory response. The mechanism by which γδ T cells are activated in this context, however, remains unclear.
Liver
The role of γδ T cells remains ill-defined in liver transplantation. Liver grafts are unique among transplanted organs in that a significant numbers of patients may develop operational tolerance. [108] [109] [110] [111] γδ TCR lymphocytes are highly represented in the human liver, comprising 24.5% compared with 6% in the peripheral blood (Figure 2) . 112 These findings are mirrored in mouse livers where approximately 20% of nonparenchymal cells are γδ TCR + lymphocytes. 113 Immediately after transplantation, there is a substantial reduction in the γδ T-cell compartment with a subsequent year-long reconstitution. 114 Patients developing spontaneous allograft tolerance have significantly increased CD3
+ γδ TCR + lymphocytes and a Vδ1: Vδ2 ratio greater than 1. 115 The expanded Vδ1 γδ T cell population displays a CD45RA + CCR7
− T-EMRA phenotype and develops independently of the thymus. 60, 116 In contrast, healthy controls exhibit a Vδ2 γδ T-cell predominance (Vδ1: Vδ2 of <1). 117, 118 Vδ1:Vδ2 ratios are highest in immunosuppression-free patients. The emergent circulating Vδ1 γδ T cells produce IL-10, thus promoting a Th2 phenotype. 117 This immune phenotype-characterized by the emergence of Vδ1 γδ T cells into the peripheral circulation-also mirrors that observed during successful pregnancy. 119 The phenotype is reversed during acute allograft rejection episodes where an increased proportion of Vδ2 γδ T cells is associated with more severe transaminitis. 120 This is also paralleled during abortive pregnancies which demonstrate a peripheral Vδ2 predominance.
A putative tolerogenic role of Vδ1 γδ T cells has been supported further by genomic studies, which are able to differentiate tolerant patients from those requiring immunosuppression using gene expression profiling. Upregulation of genes producing the δ chain of γδTCR has been observed in spontaneously tolerant patients. These include the T cell receptor δ, soluble T cell receptor delta chain, and T-cell receptor delta diversity 3 loci. 115 In 1 study, all Vδ1 γδ T cells from patients who spontaneously tolerated hepatic allografts exhibited an identical complementarity determining region 3 (CDR3) that was not found in immunosuppressed patients or those experiencing chronic rejection. 121 A significantly increased γδ T-cell infiltrate producing IL-10 and IL-4 in immunologically unresponsive rats after pretransplantation transfusion with donor-specific blood has been observed. 122 This raises the possibility of hepatic-resident γδ T cell populations that could be targeted to induce immune tolerance. However, evidence is far from conclusive. For example, a decreased percentage of γδ T cells to less than 10% in spontaneously tolerated hepatic allografts and an increased percentage in acutely rejecting livers has been shown. 113 Others have found similar percentages of γδ T cells in patients with stable graft function and those experiencing varying degrees of cellular rejection. 123 IL-17-producing γδ T cells, activated by hepatic stellate cells, have a role in the pathogenesis of liver fibrosis, although there is scarce data at present examining their role in chronic liver transplant rejection. 124 
Hematopoietic Stem Cell Transplantation
Hematopoietic stem cell transplantation (HSCT) offers potential insights into γδ T cell repopulation kinetics, participation in graft-versus-host disease (GVHD), and contribution to the graft-versus-leukemia (GVL) effect. Recent studies have demonstrated increased disease-free survival and abrogated bacterial infections with no increase in GVHD after enhanced reconstitution of the γδ T cell compartment. [125] [126] [127] [128] In mice, γδ T cells promote engraftment, enhance hematopoietic reconstitution, and augment donor cell chimerism after allogeneic HSCT. 129 After myeloablation and HSCT, the γδ T-cell compartment is promptly reconstituted and precedes the αβ lymphocyte compartment repopulation. Reconstituted γδ T cells are fundamentally different to the pretransplantation γδ T cell repertoire and somewhat different to the TRD and TRG repertoire of the donor. 7, 40, 130 Graft-derived lymphocytes expand after alloHSCT as demonstrated by matched CDR3 regions of TCRVδ1 between donor and recipient at 1.5 years posttransplant.
131 Donor T-cell engraftment in the thymus and spleen is significantly enhanced by pre and posttransplant γδ T-cell infusions. 132 A role for the thymus in regulation of γδ T-cell expansion is also alluded to by data from an athymic patient treated with allogeneic bone marrow transplantation demonstrating a persistently elevated double-negative peripheral phenotype of which 88% were CD3 + CD4 − CD8 − γδ T lymphocytes. 133 Cytomegalovirus reactivation is a significant concern after HSCT. Vδ2 neg γδ T-cell expansion after CMV reactivation has been identified in patients undergoing HSCT, akin to that observed after renal transplantation. Expanded Vδ2 neg γδ T cells have an increased effector or terminally differentiated phenotype with fewer central memory cells. They are able to lyse primary leukemic blasts (but not other tumor cell lines) in vitro. 40, 134 Proliferated clones after CMV infection also demonstrate a long CDR3 Vδ2TCR δ sequence, mirroring that observed in tolerant liver transplant recipients. 7, 121 Vδ2 neg γδ T cells also have a role in EBV control. In a cord blood transfusion recipient who received CMV neg EBV pos cord blood, there was a massive, sustained, and non-neoplastic Vδ1 + γδ T-cell expansion from 4% to 47% of circulating CD3 + lymphocytes. 135 These expanded γδ T cells demonstrated anti-EBV cytolytic activity.
Evidence for the role of γδ T cells in GVHD is mixed. Bone marrow-derived alloHSCT administration of γδ T cells in isolation reduces the risk of GVHD, whereas coadministration with αβ lymphocytes exacerbates it. 136 Naïve γδ T-cell frequencies are lower in patients who experience GVHD. 137 A subpopulation of Treg cells that expresses γδ TCR (FOXP3 + γδTCR + ) has been described, which is decreased in patients experiencing chronic GVHD and associated with reduced levels of TGFβ1, IL-2, and increased TNFα. 138 On the other hand, increased graft concentrations of γδ TCR + lymphocytes are associated with an increased frequency of grade II-IV GVHD. 139 There is less histopathological evidence of GVHD in mice administered an anti-γδ TCR. 140 However, there is evidence that γδTCR + cell infusion causes GVHD in mice expressing nonclassical MHC class Ib gene products, but not in mice without. 141 Harnessing the ability of γδ T cells to identify and lyse malignant cells is of potential benefit in the context of hematological malignancy, and evidence thus far demonstrates the feasibility of this approach. Human Vδ2Vγ9 γδ T cells expanded in vitro with zoledronic acid have potentiated cytotoxicity against primary leukemic blasts, whereas donorderived Vδ1
− γδ T cells are activated and proliferate in response to recipient primary acute lymphoblastic leukemia (ALL) blasts. 40, 142 This functionality of γδ T cells may underlie the finding that patients treated for ALL or acute myeloid leukemia with donor alloHSCT have increased leukemia-free survival that correlates with the number of γδ T cells. 125 
Skin
The role of lymphocyte populations in the rejection of skin grafts is well established and demonstrated by TCRβ and TCRγ knockout mice that tolerate grafts for longer than 160 days. 143 However, there are mixed data regarding the relative contribution of γδ T cells in alloreactive pathways. The picture is further obscured by the intraspecies variation of γδ T-cell subpopulations. Dendritic epidermal T cells are the major epidermal T lymphocyte population in mice and rats, whereas smaller populations of γδ TCR + epidermal lymphocytes exist in humans. [144] [145] [146] These cells contribute to tissue homeostasis through cytokine secretion and survey tissue for markers of damage, demonstrated by an increased rate of skin cancer progression in TCRδ −/− mice. 29 Dendritic epidermal T cells have been observed to cluster with Langerhans cells (LC) as they migrate from the epidermis to secondary lymphoid structures. 147 Whether DETCs function as antigenpresenting cells (APCs) or contribute toward the functional maturation of migratory LCs is unknown.
Vγ4 γδ T cells migrate from the dermis to the epidermis via a chemokine ligand 20 (CCL20)-chemokine receptor 6 (CCR6) pathway in response to skin graft revascularization. Here, they contribute to a pro-inflammatory microenvironment through the production of IL-17A and IFN-γ, resulting in accelerated graft rejection. The response is potentiated by IL-23 and IL-1β. 148 TCRδ −/− mice demonstrate impaired CD8 + lymphocyte priming and dendritic cell migration. 149 γδ T cells are sufficient for graft rejection in TCRαβ-deficient mice upon exposure to the nonclassic MHC antigen Qa-1, although in this model no rejection results from major or minor histocompatibility complex-mismatched grafts. 46 There is also evidence for an immunomodulatory role of γδ T cells in skin transplantation. Portal vein (PV) immunization of the graft recipient with hybridoma cells prior to skin grafting induces oligoclonal γδ TCR + cell expansion and is associated with improved graft survival, enhanced production of IL-4 and IL-10, and suppression of IL-2 and IFN-γ production. 150, 151 This effect is abrogated in γδ TCR knockout mice and by administration of anti-IL-10 and anti TGF-β. 152, 153 Two novel molecules proposed to play a role in both successful pregnancy and allograft tolerance are CD200, expressed on dendritic cells and which augments graft survival, and MD-1, which promotes graft rejection. In a mouse model, the rate of skin graft rejection is decreased by infusion of anti-MD1, whereas anti-CD200 blocks the protection afforded by pretransplantation PV immunization. 154 Expansion of γδ TCR + lymphocytes in lymphoid organs after anti-TCRαβ administration has also been shown, which is associated with improved graft survival and preserved antibacterial action. 43 
Other Transplants
The required immunosuppression in small bowel transplantation is significant, in part due to considerable intraepithelial lymphocyte (iEL) populations and current limitations with ex vivo depletion. 155 γδ T cells may comprise up to 50% of iELs. In 1 study, increased graft and animal survival was observed after PV immunization of rats with donor dendritic cells cultured ex vivo from bone marrow aspirates. The improved survival after small bowel transplantation in these rats was associated with increased γδ T-cell infiltration into the graft, with this effect abrogated by depletion of γδ T cells from the adoptive transfer. 156, 157 Again, γδ T cells produced a Th2-like cytokine phenotype through production of IL-4, IL-10, and TGFβ. 158 Administration of the monoclonal antibody anti-CD52 (alemtuzumab) prominently depletes the donor-derived γδTCR + iEL compartment in a mouse model of small bowel transplantation. 159 In a mouse model of islet transplantation, long-term survivors after transplantation were observed to have a significant increase in the proportion of CD3 + lymphocytes expressing a γδ TCR. 160 Anterior chamber-associated immune deviation, the process by which delayed-type hypersensitivity is averted after inoculation of the anterior chamber of the eye with allogeneic material, prevents immune-mediated optic distortion. This immune privilege results in high corneal graft survival. However, infusion of anti-γδ TCR Ab causes rejection rates to increase from 20% to 75% through inhibition of anterior chamber-associated immune deviation formation. 161 Mechanistically, it is thought that γδ T cells act via the effector arm of the immune response and are required for the recruitment of Treg cells.
CONCLUSIONS
There is an incomplete understanding of γδ T biology in transplantation. As highlighted above, γδ T-cell behavior is dictated both by their ontogeny and by the specific environment in which they are activated. It is clear that γδ T cells are able to drive inflammatory responses through innate-like recognition of tissue damage and the recruitment of adaptive immune cells. Here, their role appears to be dictated by their production of IL-17 which is known to be relevant for the rejection of some types of transplants but not others. Conversely, through the production of Th2-type cytokines, they are able to dampen immune-mediated inflammatory responses and promote tolerance to transplants. Assigning a single role for γδ T cells in transplantation as either beneficial or detrimental is not possible, given their wide-ranging activity in both innate and adaptive settings. Further work is required to untangle these conflicting phenotypes, discover activating ligands, and develop potential targets for therapeutic intervention. It is clear that γδ T cells must now be viewed with the importance they deserve in transplantation.
